Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.

NCT01770210 is registered in ClinicalTrials.gov with Elpen Pharmaceutical Co. Inc. as lead sponsor.

NCT NCT01770210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01770210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.
Lead sponsor
Elpen Pharmaceutical Co. Inc.
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
July 31, 2014
Enrollment
670 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disorders